Comparative Study of Augmented Classical Least Squares Models for UV Assay of Co-Formulated Antiemetics Together with Related Impurities.
DOSC/CLS
NAP/CLS
OSC/CLS
classical least squares
independent test set
training set
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
12 Oct 2023
12 Oct 2023
Historique:
received:
03
09
2023
revised:
05
10
2023
accepted:
09
10
2023
medline:
30
10
2023
pubmed:
28
10
2023
entrez:
28
10
2023
Statut:
epublish
Résumé
The classical least squares (CLS) model and three augmented CLS models are adopted and validated for the analysis of pyridoxine HCl (PYR), cyclizine HCl (CYC), and meclizine HCl (MEC) in a quinary mixture with two related impurities: the CYC main impurity, Benzhydrol (BEH), which has carcinogenic and hepatotoxic effects, and the MEC official impurity, 4-Chlorobenzophenone (BEP). The proposed augmented CLS models are orthogonal signal correction CLS (OSC-CLS), direct orthogonal signal correction CLS (DOSC-CLS), and net analyte processing CLS (NAP-CLS). These models were applied to quantify the three active constituents in their raw materials and their corresponding dosage forms using their UV spectra. To evaluate the CLS-based models sensibly, we design a comparative study involving two sets: the training set to construct models and the validation set to assess the prediction abilities of these models. A five-level, five-factor calibration design was established to produce 25 mixtures for the calibration set. In addition, 16 experiments were performed for a test set distributed equally between the in-space and out-space samples. The primary criterion for comparing the models' performance was the validation set's root mean square error of prediction (RMSEP) value. Finally, augmented CLS models showed acceptable results for assaying the three analytes. The results were compared statistically with the reported HPLC methods; however, the DOSC-CLS model proved the best for assaying the dosage forms.
Identifiants
pubmed: 37894524
pii: molecules28207044
doi: 10.3390/molecules28207044
pmc: PMC10609573
pii:
doi:
Substances chimiques
Antiemetics
0
Meclizine
3L5TQ84570
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Researchers Supporting Project, King Saud University, Riyadh, Saudi Arabia
ID : RSPD2023R812
Organisme : Princess Nourah bint Abdulrahman University researcher supporting project, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
ID : PNURSP2023R08
Références
J Pharm Biomed Anal. 2003 Jun 1;32(2):277-86
pubmed: 12763537
Farmaco. 2004 Sep;59(9):713-22
pubmed: 15337437
Toxicology. 2000 Dec 7;156(1):27-36
pubmed: 11162873
J AOAC Int. 2022 Mar 15;105(2):630-640
pubmed: 34672335
J Sep Sci. 2015 Mar;38(5):757-63
pubmed: 25545351
Food Chem Toxicol. 2007 May;45(5):843-51
pubmed: 17187913
J AOAC Int. 2018 Mar 1;101(2):427-436
pubmed: 28766490
J AOAC Int. 2017 Mar 1;100(2):414-421
pubmed: 28118132
Spectrochim Acta A Mol Biomol Spectrosc. 2020 Apr 15;231:118116
pubmed: 32014657
Pak J Pharm Sci. 2007 Apr;20(2):149-56
pubmed: 17416572